Industry News
Major breakthrough in hepatitis C vaccine development
Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could be the first ever preventative vaccine for the virus. [ + ]
Doors open for new medical research
Lifesaving medical research received a major boost yesterday, with the opening of the final stage of The John Curtin School of Medical Research (JCSMR) at The Australian National University. [ + ]
Olympic lab leaves life sciences legacy
The London 2012 anti-doping facilities, operated by King’s College London, will be developed after the Olympic and Paralympic Games into a world-class resource that could help revolutionise healthcare. [ + ]
Feature: Born or made?
What makes a champion? With Olympic fever running hot, this is a question that is likely to have been asked more than a few times in recent weeks both in living rooms and locker rooms worldwide. [ + ]
UNCOVER: unlocking Australia’s hidden mineral wealth
The Australian Academy of Science has welcomed the launch of UNCOVER: Searching the deep earth, a visionary new project to unlock Australia’s enormous potential mineral wealth. [ + ]
Busselton people help type 2 diabetes world research
Busselton residents and researchers from The University of Western Australia have contributed to a worldwide scientific collaboration that has identified new genetic links in the quest to map the biological pathways that cause diabetes. [ + ]
Stronger patents help protect innovative Australian exporters
Innovative Australian exporters will have a better chance of protecting their technology overseas following the recent approval of stronger patent standards. [ + ]
Nexvet signs first deal for veterinary drug
Veterinary drug developer Nexvet has signed the first licensing deal covering a biologic drug adapted for animal use using its PETization process. [ + ]
Minister to open new medical research facility
The Hon Tanya Plibersek, Minister for Health, will be at The Australian National University on Monday 13 August to open the third and final stage of The John Curtin School of Medical Research (JCSMR). [ + ]
The world’s first (official) biosimilar antibody goes to … rheumatoid arthritis
On 23 July, South Korean biosimilar manufacturer Celltrion announced the approval of Remsima (CT-P13), a biosimilar antibody, by the Korean Food and Drug Administration. Remsima is a biosimilar version of Johnson & Johnson’s Remicade (infliximab), which was one of the first monoclonal antibody TNF inhibitors approved for the treatment of rheumatoid arthritis (RA). [ + ]
Doping detection stays a neck ahead
While the eyes of the world may currently be focused on the Olympics, human sport is not the only area where drug testing is routinely carried out. Horse racing is a massive worldwide industry and regular testing is essential to maintain its integrity. [ + ]
RS Components and SMC Corporation extend global partnership to Australia and New Zealand
RS Components, the trading brand of Electrocomponents plc, has extended its global partnership with the SMC Corporation, specialist in pneumatics and automation, into Australia and New Zealand. [ + ]
Advanced Leadership Program scholarships for AusBiotech members
Woman & Leadership Australia has announced two $11,000 scholarships to be awarded to AusBiotech members to assist their participation in the Advanced Leadership Program. [ + ]
Bioniche E. coli vaccine cleared for import into UK
A UK department has granted veterinarians special dispensation to import a cattle vaccine against E. coli O157 developed by Bioniche (ASX:BNC). [ + ]
Rice study could save farmers billions
Breeding rice plants that retain more phosphorus in the straw, which is returned to the soil after harvest, could reduce the use of phosphorus fertiliser and save farmers billions of dollars, according to Southern Cross University researcher Dr Terry Rose. [ + ]